SE0100195L - Evaluation procedures for anti-tumor activity - Google Patents

Evaluation procedures for anti-tumor activity

Info

Publication number
SE0100195L
SE0100195L SE0100195A SE0100195A SE0100195L SE 0100195 L SE0100195 L SE 0100195L SE 0100195 A SE0100195 A SE 0100195A SE 0100195 A SE0100195 A SE 0100195A SE 0100195 L SE0100195 L SE 0100195L
Authority
SE
Sweden
Prior art keywords
tumor activity
evaluation procedures
koji
glucan
fermenting
Prior art date
Application number
SE0100195A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE0100195D0 (en
Inventor
Kozo Niwa
Original Assignee
Kozo Niwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwa filed Critical Kozo Niwa
Publication of SE0100195L publication Critical patent/SE0100195L/en
Publication of SE0100195D0 publication Critical patent/SE0100195D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method for strengthening an antitumor activity by roasting a polysaccharide or mushroom containing b -glucan by far infrared rays, then, fermenting by adding "Koji", and further making an oily agent. Also claimed is a method of evaluating the efficacy of the drug by an in vitro method based on lipid peroxidation.
SE0100195A 1998-09-17 2001-01-24 Evaluation procedures for anti-tumor activity SE0100195D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (en) 1998-09-17 1998-11-13 Method of strengthening antitumor activity of crude drug, composition containing crude drug for strengthening antitumor activity, method of evaluating antitumor effectivity treated by crude drug and method of evaluating antitumor effectivity of crud drug

Publications (2)

Publication Number Publication Date
SE0100195L true SE0100195L (en) 2001-01-24
SE0100195D0 SE0100195D0 (en) 2001-01-24

Family

ID=26546176

Family Applications (2)

Application Number Title Priority Date Filing Date
SE9903307A SE9903307L (en) 1998-09-17 1999-09-16 Amplification of antitumor activity of natural drugs from fungi
SE0100195A SE0100195D0 (en) 1998-09-17 2001-01-24 Evaluation procedures for anti-tumor activity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE9903307A SE9903307L (en) 1998-09-17 1999-09-16 Amplification of antitumor activity of natural drugs from fungi

Country Status (19)

Country Link
JP (1) JP2000159682A (en)
KR (1) KR20000023206A (en)
CN (1) CN1255376A (en)
AU (1) AU4486299A (en)
BE (1) BE1012725A5 (en)
CA (1) CA2282234A1 (en)
DE (1) DE19944695A1 (en)
DK (1) DK199901235A (en)
ES (1) ES2155802B1 (en)
FR (2) FR2783426A1 (en)
GB (2) GB9920710D0 (en)
ID (1) ID23150A (en)
IL (1) IL131722A0 (en)
IS (1) IS5183A (en)
IT (1) IT1307267B1 (en)
NL (2) NL1013049C2 (en)
NO (1) NO994463L (en)
SE (2) SE9903307L (en)
SG (1) SG76631A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100391439C (en) * 2001-04-27 2008-06-04 味之素株式会社 Immunopotentiators
WO2002090559A1 (en) * 2001-05-07 2002-11-14 Biohub Co., Ltd. A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (en) * 2001-05-21 2010-07-14 コンビ株式会社 Composition for controlling pathogen infection
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk Drugs for diabetes
JP4681801B2 (en) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 Angiogenesis inhibitor and method for producing the same
JP4826696B2 (en) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 Angiogenesis inhibitors
TWI330533B (en) 2002-05-15 2010-09-21 Bhn Co Ltd Composition for angiogenesis inhibition, neoplasm inhibition,or immunostimulation
JP2005089417A (en) * 2003-09-19 2005-04-07 Noevir Co Ltd Composition for prevention/treatment of diabetes
JP4587441B2 (en) * 2004-02-12 2010-11-24 株式会社クレハ Novel diabetes treatment and food
WO2006030750A1 (en) 2004-09-17 2006-03-23 Ssi Co., Ltd. Extract from agaricus blazei murrill capable of inhibiting breast cancer
JP2006273835A (en) * 2005-03-04 2006-10-12 Michishi Tani Therapeutic agent for malignant tumor and food or beverage containing the same
WO2011014729A1 (en) * 2009-07-31 2011-02-03 Yukiguni Maitake Co., Ltd. Maitake mushroom coffee
WO2011081024A1 (en) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 Umami food, and method for producing same
CN106333969A (en) * 2016-08-30 2017-01-18 青海民族大学 Agaricus gennadii HDAC1 enzyme inhibition effective part and preparation method and application
CN106309511A (en) * 2016-08-30 2017-01-11 青海民族大学 Effective part of agaricus gennadii for inhibiting CDC25 enzyme as well as preparation method and application of effective part
US20200397817A1 (en) * 2017-11-30 2020-12-24 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102602787B1 (en) * 2020-12-16 2023-11-17 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Sparassis crispa
KR102646421B1 (en) * 2020-12-16 2024-03-12 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Grifola frondosa
KR102584680B1 (en) * 2020-12-17 2023-10-06 대한민국 Method for manufacturing tea of Lentinula edodes tea improved physiological activities and nutrition components

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (en) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (en) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd Food having antitumor function and production thereof
JP3357383B2 (en) * 1991-08-14 2002-12-16 昌宏 黒田 Low molecular weight plant composition
JP2955126B2 (en) * 1992-06-22 1999-10-04 笑代 丹羽 Pharmaceutical oleaginous preparation, food oleaginous preparation and production method thereof
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
NL1019705C2 (en) 2002-03-26
GB9920710D0 (en) 1999-11-03
GB9921387D0 (en) 1999-11-10
DE19944695A1 (en) 2000-03-30
SE9903307D0 (en) 1999-09-16
NO994463D0 (en) 1999-09-15
FR2788697A1 (en) 2000-07-28
NO994463L (en) 2000-03-20
ITTO990784A1 (en) 2001-03-14
ID23150A (en) 2000-03-23
IS5183A (en) 2000-03-17
SE9903307L (en) 2000-03-18
BE1012725A5 (en) 2001-02-06
SG76631A1 (en) 2000-11-21
GB2341800A (en) 2000-03-29
NL1013049A1 (en) 2000-03-21
IL131722A0 (en) 2001-03-19
NL1013049C2 (en) 2002-01-11
JP2000159682A (en) 2000-06-13
ITTO990784A0 (en) 1999-09-14
ES2155802A1 (en) 2001-05-16
ES2155802B1 (en) 2001-12-01
FR2783426A1 (en) 2000-03-24
NL1019705A1 (en) 2002-01-29
CA2282234A1 (en) 2000-03-17
SE0100195D0 (en) 2001-01-24
CN1255376A (en) 2000-06-07
DK199901235A (en) 2000-03-18
KR20000023206A (en) 2000-04-25
AU4486299A (en) 2000-03-30
IT1307267B1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
SE0100195L (en) Evaluation procedures for anti-tumor activity
TR199700358A2 (en) �nterferon birle�imler.
BR9916857A (en) 4 heteroaryl diarylamines
PT983286E (en) AMINOALQUIL-GLYCOSAMINE-PHOSPHATE COMPOUNDS AND THEIR USE AS ADJUVANTS EIMUNOEFECTORS
NL1003465A1 (en) Implantable transponder and improved formulation method.
FR2786769B1 (en) 2,5-DIAZABICYCLO [2.2.1] HEPTANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2809730B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANEBENZOXAZOLE, -BENZOTHIAZOLE AND -BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
TR199801871A3 (en) Biphenylsulfonylcyanamides production method and their use as drugs.
IT1293910B1 (en) ARMREST OF CHAIR, AND CHAIR USING SUCH ARMREST.
DE60006448D1 (en) Mercapto alcohol compounds than as flavorings
TR28331A (en) 13-substituted milbemycin derivatives, their preparation and uses.
FR2845388B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
EP0547102A4 (en)
FR2779429B1 (en) OXINDOLE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS
ATE305455T1 (en) 1,3-DIHYDRO-2H-IMIDAZOLE-2-ONE DERIVATIVES WITH PDEIV AND CYTOKINE INHIBITING ACTIVITY
EP0836480A4 (en) Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
IL138117A0 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them
DE69613793D1 (en) Ophthalmic Cromolyn gel preparation
IT1312090B1 (en) INACTIVATED MICROORGANISMS INCLUDING SOLUBLE AND / SOLUBILIZABLE SUBSTANCES FOR PHARMACOLOGICAL ACTIVITY AND / OR NUTRITIONAL SUBSTANCES
WO2003060467A3 (en) Method for analyzing effects of medical agents
KR970000074A (en) Chitosan-containing health food and its manufacturing method
DE69925916D1 (en) Immunostimulatory Phellinus ssp. Polysaccharide and use
FR2784379B1 (en) QUINAZOLINEDIONE DERIVATIVES, THEIR PREPARATIONS AND THERAPEUTIC APPLICATIONS
BR9802715C1 (en) Method of denaturing toxic and denatured toxic products obtained
ITTO950013V0 (en) PENDANT FOR KEYCHAINS AND / OR SIMILAR, PREPARED FOR COMBINATION GAMES.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 0100195-7

Format of ref document f/p: F